Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 1
2014 1
2015 1
2016 1
2022 3
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Drs. Bessette and Kinch reply.
Bessette L, Kinch CD. Bessette L, et al. Among authors: kinch cd. J Rheumatol. 2023 Apr;50(4):579-580. doi: 10.3899/jrheum.220909. Epub 2022 Oct 15. J Rheumatol. 2023. PMID: 36243412 No abstract available.
Molecular interactions in cancer cell metastasis.
Brooks SA, Lomax-Browne HJ, Carter TM, Kinch CE, Hall DM. Brooks SA, et al. Among authors: kinch ce. Acta Histochem. 2010;112(1):3-25. doi: 10.1016/j.acthis.2008.11.022. Epub 2009 Jan 21. Acta Histochem. 2010. PMID: 19162308 Review.
Efficacy and safety of tofacitinib in Chinese patients with active psoriatic arthritis: a phase 3, randomised, double-blind, placebo-controlled study.
Leng X, Lin W, Liu S, Kanik K, Wang C, Wan W, Jiang Z, Liu Y, Liu S, Zhang Z, Zhang Z, Xu J, Tan W, Hu J, Li J, Liu J, Gunay LM, Dina O, Kinch C, Zeng X. Leng X, et al. Among authors: kinch c. RMD Open. 2023 Jan;9(1):e002559. doi: 10.1136/rmdopen-2022-002559. RMD Open. 2023. PMID: 36720560 Free PMC article. Clinical Trial.
Sex differences in the efficacy, safety and persistence of patients with psoriatic arthritis treated with tofacitinib: a post-hoc analysis of phase 3 trials and long-term extension.
Eder L, Gladman DD, Mease P, Pollock RA, Luna R, Aydin SZ, Ogdie A, Polachek A, Gruben D, Cadatal MJ, Kinch C, Strand V. Eder L, et al. Among authors: kinch c. RMD Open. 2023 Mar;9(1):e002718. doi: 10.1136/rmdopen-2022-002718. RMD Open. 2023. PMID: 36958766 Free PMC article. Clinical Trial.
Effectiveness and Safety of Tofacitinib in Canadian Patients With Rheumatoid Arthritis: Primary Results From a Prospective Observational Study.
Haraoui B, Khraishi M, Choquette D, Lisnevskaia L, Teo M, Kinch C, Galos C, Roy P, Gruben D, Woolcott JC, Vaillancourt J, Sampalis JS, Keystone EC; Canadian Tofacitinib for Rheumatoid Arthritis Observational Investigators. Haraoui B, et al. Among authors: kinch c. Arthritis Care Res (Hoboken). 2023 Feb;75(2):240-251. doi: 10.1002/acr.24966. Epub 2022 Oct 10. Arthritis Care Res (Hoboken). 2023. PMID: 35678771 Free PMC article.
13 results